Valeant Pharma (NYSE:VRX) Intraday Stock Chart Today : Monday 20 October 2014 LAVAL, Quebec , Oct. 20, 2014 /PRNewswire/ -- 2014 Third... ...http://in.advfn.com/p.php?pid=nmona&article=64097924
10 therapies have outgrown the IPM growth and six therapies have double digit growths The Indian pharmaceutical market (IPM) clocked Rs 7097... ...http://pharma.financialexpress.com/sections/market-section/4470-ipm-clocks-rs-7097-cr-in-aug-2014
Expect to file in the U.S. in First Half of Q2 2015 Expect to launch in the U.S. in First Half of 2016 Peak U.S. sales ~$500 million+, Peak... ...http://in.advfn.com/p.php?pid=nmona&article=63801805
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Valeant Pharmaceuticals... ...http://www.pressreleasepoint.com/ftc-approves-final-order-preserving-competition-markets-acne-treatments
Tretinoin , Generic Retin-a , Retin-a...